Shofu Inc.
Financial Results Announcement for 2026｜Sales of 39.9 billion yen (+3.3% YoY)
Matsukaze achieved consolidated sales of 39.994 billion yen (YoY +3.3%) for the fiscal year ending March 2026. Operating income and R&D expenses also increased, indicating steady performance this term.
Key Figures
- Sales: 39,994 million yen（YoY +3.3%）
- Operating Income: 18,513 million yen（YoY +5.2%）
- R&D Expenses: 2,165 million yen（YoY +180 million yen）
AI要約
Overview of Performance
For the fiscal year ending March 2026, Matsukaze recorded consolidated sales of 39.994 billion yen (YoY +3.3%), maintaining steady growth. Operating income was 18.513 billion yen (YoY +5.2%), with net income also on an upward trend, and R&D expenses increased. The overseas sales ratio was approximately 58.8%, with especially strong performance in the Dental sector. Segments such as industrial abrasives and chemical products also showed steady progress.
Outlook and Impact on Shareholders
Matsukaze will continue to strengthen R&D and overseas expansion aiming for sales growth. Although details regarding dividends and capital policies are not provided, the solid performance suggests potential for shareholder returns. Considering currency fluctuations, the company expects to sustain stable growth.
Sales Trend
Operating Income Trend
Segment Revenue Breakdown
Forecast vs Actual Comparison
| Item | 2026 Actual | 2027 Forecast |
|---|---|---|
| Sales | 39,994 | 42,958 |
| Operating Income | 18,513 | 20,964 |
Matsukaze
Company overview · Stock price · Financial data · All IR
